Trexquant Investment’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Trexquant Investment’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,711	Closed	-$281K	–	1485
2016 Q4	$281K	Buy	+7,711	New	+$273K	0.04%	677

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Trexquant Investment's CLCD Position: Q1 2017 in Review

Trexquant Investment sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 7,711 shares — an estimated $281K sold.

Trexquant Investment first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $281K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Trexquant Investment reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Trexquant Investment sold 7,711 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $281K.
Trexquant Investment first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
Trexquant Investment's CoLucid Pharmaceuticals, Inc. position peaked at $281K in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Trexquant Investment's 13F filing for Q1 2017, filed 9 May 2017.